Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for OrthoPediatrics Corp. (KIDS : NSDQ)
 
 • Company Description   
OrthoPediatrics Corp. is a medical device company. It markets surgical systems for trauma and deformity, bone fractures and reconstruction procedures. OrthoPediatrics Corp. is based in NEW YORK.

Number of Employees: 133

 
 • Price / Volume Information   
Yesterday's Closing Price: $42.11 Daily Weekly Monthly
20 Day Moving Average: 135,441 shares
Shares Outstanding: 20.23 (millions)
Market Capitalization: $851.88 (millions)
Beta: 0.88
52 Week High: $73.91
52 Week Low: $36.71
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -13.62% -5.71%
12 Week -14.76% -7.87%
Year To Date -29.65% -16.67%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2850 Frontier Drive
-
Warsaw,IN 46582
USA
ph: 574-268-6379
fax: 574-269-3692
tbui@theruthgroup.com http://www.orthopediatrics.com
 
 • General Corporate Information   
Officers
David R. Bailey - President and Chief Executive Officer
Fred L. Hite - Chief Financial Officer and Chief Operating Office
Mark C. Throdahl - Director
Bryan W. Hughes - Director
Terry D. Schlotterback - Director

Peer Information
OrthoPediatrics Corp. (ABMD)
OrthoPediatrics Corp. (DMDS)
OrthoPediatrics Corp. (CPWY.)
OrthoPediatrics Corp. (EQUR)
OrthoPediatrics Corp. (ECIA)
OrthoPediatrics Corp. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 68752L100
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/03/22
Share - Related Items
Shares Outstanding: 20.23
Most Recent Split Date: (:1)
Beta: 0.88
Market Capitalization: $851.88 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.14 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.79 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/03/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 3.68
Price/Cash Flow: -
Price / Sales: 8.52
EPS Growth
vs. Year Ago Period: -20.00%
vs. Previous Quarter: -25.00%
Sales Growth
vs. Year Ago Period: 9.11%
vs. Previous Quarter: -5.63%
ROE
03/31/22 - -6.98
12/31/21 - -6.54
09/30/21 - -7.10
ROA
03/31/22 - -5.10
12/31/21 - -4.74
09/30/21 - -5.13
Current Ratio
03/31/22 - -
12/31/21 - 4.50
09/30/21 - 4.83
Quick Ratio
03/31/22 - -
12/31/21 - 2.56
09/30/21 - 2.86
Operating Margin
03/31/22 - -15.55
12/31/21 - -14.85
09/30/21 - -17.32
Net Margin
03/31/22 - -14.98
12/31/21 - -16.58
09/30/21 - -32.93
Pre-Tax Margin
03/31/22 - -
12/31/21 - -17.73
09/30/21 - -34.68
Book Value
03/31/22 - -
12/31/21 - 11.45
09/30/21 - 11.24
Inventory Turnover
03/31/22 - -
12/31/21 - 0.44
09/30/21 - 0.39
Debt-to-Equity
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - -
12/31/21 - 0.40
09/30/21 - 0.42
 

Powered by Zacks Investment Research ©